Golden
Lumira Ventures

Lumira Ventures

A venture capital and private equity firm making late stage investments in biotherapeutic, medical technology, and consumer health companies.

Lumira Ventures is a venture capital and private equity firm making late stage investments in biotherapeutic, medical technology, and consumer health companies that is headquartered in Toronto, Ontario and was founded in 1989 by Peter van der Velden. The firm also has offices in Montreal, Quebec; Vancouver, British Columbia; and Boston, Massachusetts.



Investments

Notable investments made by Lumira Ventures include: AmacaThera, Antios Therapeutics, Antiva Biosciences, Aurinia Pharmaceuticals, Bardy Diagnostics, BAROnova, Cardiac Dimensions, MAKO Surgical, Corus Pharmaceuticals, Morphotek, Celtaxsys, KAI Pharmaceuticals, Pharmasset, Alveolus, Ception Therapeutics, and Zymeworks. 



Philanthropy

Companies and organizations receiving philanthropy from Lumira Ventures include: BC's Children's Hospital, SickKids Foundation, Fondation de l’Hôpital Maisonneuve-Rosemont, St. Joseph’s Healthcare Foundation, Heart and Stroke Foundation of Canada, Sunnybrook Foundation, Montreal Heart Institute Foundation, Trillium Healthcare Partners Foundation, Princess Margaret Cancer Foundation, VGH & UBC Hospital Foundation, William Osler Health System Foundation, and St. Michaels Foundation. Events and foundations supported by Lumira Ventures are the Foundation Fighting Blindness, Chrons & Colitis, Cycle for Sight, and Heart and Stroke - Big Bike. 



Timeline

Funded Companies

3 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Antios Therapeutics is a biopharmaceutical company.

AmacaThera is an Ontario-based company.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References